Incontinence-associated Dermatitis
17
1
1
9
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
17.6%
3 terminated out of 17 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Prevention of Incontinence-associated Dermatitis
COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis
How Wet Pads Affect Elderly Skin: Measuring Changes in the Skin Barrier
Prevention of Incontinence-associated Dermatitis and Maintenance of Local Skin Microclimate
Reducing Skin Surface pH During Skin Occlusion: Changes to Skin Microbiome and Skin Parameters
Comparative Study to Assess an Advanced Skin Protectant in the Management of Incontinence-associated Dermatitis
Prevention of Incontinence-associated Dermatitis and Maintenance of Local Skin Microclimate：A Multicenter Study
Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections
Seeing Red: Clinical Assessment Tools for Clinical Trial Decision Support
Can the Use of Uricap Female Device Lead to Better Care for Women > 75+Years?
Histopathological Comparison Between Superficial Pressure Ulcers and Incontinence-associated Dermatitis
Enhancing SKIN Health and Safety in Aged CARE
Evaluation of Skin Cleansers and Skin Protectants in Management of Incontinence-associated Dermatitis
Pressure Ulcer Prevention: a Turn and Positioning System Combined With Incontinence Care and Tailored/Standard Repositioning
Developing Of A New Incontinence Care Product
Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence
Comparison of Wash Wipes and Standard Care in the Prevention of Incontinence-associated Dermatitis in Elderly